Literature DB >> 20352075

Is systems biology the key to preventing the next pandemic?

Jennifer R Tisoncik1, Sarah E Belisle, Deborah L Diamond, Marcus J Korth, Michael G Katze.   

Abstract

Sporadic outbreaks of epizootics including SARS coronavirus and H5N1 avian influenza remind us of the potential for communicable diseases to quickly spread into worldwide epidemics. To confront emerging viral threats, nations have implemented strategies to prepare for pandemics and to control virus spread. Despite improved surveillance and quarantine measures, we find ourselves in the midst of a H1N1 influenza pandemic. Effective therapeutics and vaccines are essential to protect against current and future pandemics. The best route to effective therapeutics and vaccines is through a detailed and global view of virus-host interactions that can be achieved using a systems biology approach. Here, we provide our perspective on the role of systems biology in deepening our understanding of virus-host interactions and in improving drug and vaccine development. We offer examples from influenza virus research, as well as from research on other pandemics of our time - HIV/AIDS and HCV - to demonstrate that systems biology offers one possible key to stopping the cycle of viral pandemics.

Entities:  

Year:  2009        PMID: 20352075      PMCID: PMC2843927          DOI: 10.2217/fvl.09.53

Source DB:  PubMed          Journal:  Future Virol        ISSN: 1746-0794            Impact factor:   1.831


  46 in total

1.  Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic.

Authors:  Niall P A S Johnson; Juergen Mueller
Journal:  Bull Hist Med       Date:  2002       Impact factor: 1.314

2.  Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice.

Authors:  G L Wolff; R L Kodell; S R Moore; C A Cooney
Journal:  FASEB J       Date:  1998-08       Impact factor: 5.191

3.  Characterization of the reconstructed 1918 Spanish influenza pandemic virus.

Authors:  Terrence M Tumpey; Christopher F Basler; Patricia V Aguilar; Hui Zeng; Alicia Solórzano; David E Swayne; Nancy J Cox; Jacqueline M Katz; Jeffery K Taubenberger; Peter Palese; Adolfo García-Sastre
Journal:  Science       Date:  2005-10-07       Impact factor: 47.728

4.  Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus.

Authors:  Darwyn Kobasa; Steven M Jones; Kyoko Shinya; John C Kash; John Copps; Hideki Ebihara; Yasuko Hatta; Jin Hyun Kim; Peter Halfmann; Masato Hatta; Friederike Feldmann; Judie B Alimonti; Lisa Fernando; Yan Li; Michael G Katze; Heinz Feldmann; Yoshihiro Kawaoka
Journal:  Nature       Date:  2007-01-18       Impact factor: 49.962

5.  Proteomic studies reveal coordinated changes in T-cell expression patterns upon infection with human immunodeficiency virus type 1.

Authors:  Jeffrey H Ringrose; Rienk E Jeeninga; Ben Berkhout; Dave Speijer
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

6.  CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms.

Authors:  Matthew J Dolan; Hemant Kulkarni; Jose F Camargo; Weijing He; Alison Smith; Juan-Manuel Anaya; Toshiyuki Miura; Frederick M Hecht; Manju Mamtani; Florencia Pereyra; Vincent Marconi; Andrea Mangano; Luisa Sen; Rosa Bologna; Robert A Clark; Stephanie A Anderson; Judith Delmar; Robert J O'Connell; Andrew Lloyd; Jeffrey Martin; Seema S Ahuja; Brian K Agan; Bruce D Walker; Steven G Deeks; Sunil K Ahuja
Journal:  Nat Immunol       Date:  2007-10-21       Impact factor: 25.606

7.  Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection.

Authors:  John G McHutchison; Gregory T Everson; Stuart C Gordon; Ira M Jacobson; Mark Sulkowski; Robert Kauffman; Lindsay McNair; John Alam; Andrew J Muir
Journal:  N Engl J Med       Date:  2009-04-30       Impact factor: 91.245

8.  Direct inhibition of CDK9 blocks HIV-1 replication without preventing T-cell activation in primary human peripheral blood lymphocytes.

Authors:  Dominic Salerno; Muneer G Hasham; Renée Marshall; Judit Garriga; Alexander Y Tsygankov; Xavier Graña
Journal:  Gene       Date:  2007-09-19       Impact factor: 3.688

9.  Dynamic host energetics and cytoskeletal proteomes in human immunodeficiency virus type 1-infected human primary CD4 cells: analysis by multiplexed label-free mass spectrometry.

Authors:  Eric Y Chan; Jennifer N Sutton; Jon M Jacobs; Andrey Bondarenko; Richard D Smith; Michael G Katze
Journal:  J Virol       Date:  2009-07-08       Impact factor: 5.103

Review 10.  Systems biology and the host response to viral infection.

Authors:  Seng-Lai Tan; Gopinath Ganji; Bryan Paeper; Sean Proll; Michael G Katze
Journal:  Nat Biotechnol       Date:  2007-12       Impact factor: 54.908

View more
  4 in total

Review 1.  The top five "game changers" in vaccinology: toward rational and directed vaccine development.

Authors:  Richard B Kennedy; Gregory A Poland
Journal:  OMICS       Date:  2011-08-04

Review 2.  Dynamics of innate immunity are key to chronic immune activation in AIDS.

Authors:  Arndt Benecke; Michael Gale; Michael G Katze
Journal:  Curr Opin HIV AIDS       Date:  2012-01       Impact factor: 4.283

Review 3.  Critical dynamics in host-pathogen systems.

Authors:  Arndt G Benecke
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

Review 4.  Bugs in the system.

Authors:  Vineet D Menachery; Ralph S Baric
Journal:  Immunol Rev       Date:  2013-09       Impact factor: 12.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.